๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The development of global consensus guidelines on the management of the diabetic foot

โœ Scribed by J. Apelqvist; K. Bakker; W. H. van Houtum; N. C. Schaper


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
161 KB
Volume
24
Category
Article
ISSN
1520-7552

No coin nor oath required. For personal study only.

โœฆ Synopsis


The future for diabetes is grave. Now described as the global epidemic of the 21st century, the increasing incidence of diabetes (in 2007 over 246 million people affected by diabetes) will place considerable strain on resources and will bring suffering to many if the preventative measures promoted by the International Diabetes Federation (IDF), the International Working Group on the Diabetic Foot (IWGDF) and other diabetes representative organizations are not put into effect.

Ulcers of the foot in diabetes are a source of major suffering and cost. Investing in a diabetic foot care guideline can be one of the most cost-effective forms of healthcare expenditure, provided the guideline is goal-focused and properly implemented. The objective of the IWGDF, founded in 1996, is to develop guidelines that will reduce the impact of diabetic foot disease through cost-effective and quality healthcare, based on the principles of evidence-based medicine. Three IWGDF working groups were invited to write specific consensus guidelines on different subjects, according to the current standards of evidence based medicine. Therefore, for the first time, new 2007 texts were produced according to a systematic review of the literature, in order to inform protocols for routine care and to highlight areas which should be considered for further study. After reaching worldwide consensus, the review reports and specific guidelines were launched in May 2007.


๐Ÿ“œ SIMILAR VOLUMES


International Consensus on the Diabetic
โœ Connor, Henry ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 55 KB ๐Ÿ‘ 2 views

diabetes plus one or more additional cardiovascular risk factor. ACE inhibitors should now be considered alongside aspirin and statins for the prevention of cardiovascular disease in this high risk population. ## Key points $ Patients with diabetes are at very high cardiovascular risk $ In the HO

Management of the diabetic Charcot foot
โœ Robert G. Frykberg; Ewald Mendeszoon ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 120 KB ๐Ÿ‘ 3 views